Gene therapy for human liver diseases

Cristiana Di Campli, Jian Wu, Antonio Gasbarrini, Giovanni Gasbarrini, Mark A Zern

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

The liver can be considered an ideal target to design gene therapy strategies because of the unique properties of hepatic cells. The great amount of work carried out in this field clearly delineates the quality of the new approaches that have been developed in the last few years and demonstrates the feasibility of this strategy in a wide range of multi-factorial and inherited disorders. However, improvement of current vectors to specifically and efficiently deliver the therapeutic gene into the target cell remains a daunting problem. In this review, we will summarize the most important approaches that are currently under investigation, the pathological conditions that can be treated by this strategy and the most important drawbacks that remain to be overcome in order to achieve long-term and high-level gene expression.

Original languageEnglish (US)
Pages (from-to)421-429
Number of pages9
JournalEuropean Journal of Gastroenterology and Hepatology
Volume11
Issue number4
StatePublished - 1999
Externally publishedYes

Keywords

  • Gene therapy
  • Liposomes
  • Liver diseases
  • Viral vectors

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Gene therapy for human liver diseases'. Together they form a unique fingerprint.

  • Cite this

    Di Campli, C., Wu, J., Gasbarrini, A., Gasbarrini, G., & Zern, M. A. (1999). Gene therapy for human liver diseases. European Journal of Gastroenterology and Hepatology, 11(4), 421-429.